DK1194161T3 - Stabile faktor VIII-sammensatninger - Google Patents

Stabile faktor VIII-sammensatninger

Info

Publication number
DK1194161T3
DK1194161T3 DK00948452T DK00948452T DK1194161T3 DK 1194161 T3 DK1194161 T3 DK 1194161T3 DK 00948452 T DK00948452 T DK 00948452T DK 00948452 T DK00948452 T DK 00948452T DK 1194161 T3 DK1194161 T3 DK 1194161T3
Authority
DK
Denmark
Prior art keywords
factor viii
stable factor
viii compositions
compositions
stable
Prior art date
Application number
DK00948452T
Other languages
Danish (da)
English (en)
Inventor
Marianne Mikaelsson
Helena Sandberg
Original Assignee
Biovitrum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27354553&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1194161(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from SE9902685A external-priority patent/SE9902685D0/xx
Priority claimed from SE0001743A external-priority patent/SE0001743D0/xx
Application filed by Biovitrum Ab filed Critical Biovitrum Ab
Application granted granted Critical
Publication of DK1194161T3 publication Critical patent/DK1194161T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK00948452T 1999-07-13 2000-07-07 Stabile faktor VIII-sammensatninger DK1194161T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9902685A SE9902685D0 (sv) 1999-07-13 1999-07-13 Stable protein compositions
US14682899P 1999-08-02 1999-08-02
SE0001743A SE0001743D0 (sv) 2000-05-11 2000-05-11 Stable protein compositions II

Publications (1)

Publication Number Publication Date
DK1194161T3 true DK1194161T3 (da) 2006-02-13

Family

ID=27354553

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00948452T DK1194161T3 (da) 1999-07-13 2000-07-07 Stabile faktor VIII-sammensatninger

Country Status (14)

Country Link
US (1) US6599724B1 (de)
EP (1) EP1194161B1 (de)
JP (1) JP4674021B2 (de)
AR (1) AR024735A1 (de)
AT (1) ATE310533T1 (de)
AU (1) AU780415B2 (de)
CA (1) CA2378751C (de)
CY (1) CY1104986T1 (de)
DE (1) DE60024268T2 (de)
DK (1) DK1194161T3 (de)
ES (1) ES2252028T3 (de)
NO (1) NO330048B1 (de)
NZ (1) NZ516400A (de)
WO (1) WO2001003726A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2244556C2 (ru) 1999-02-22 2005-01-20 Юниверсити Оф Коннектикут Новые не содержащие альбумин составы фактора viii
KR20040065278A (ko) * 2001-12-21 2004-07-21 노보 노르디스크 에이/에스 변경된 인자 ⅶ 폴리펩티드의 액체 조성물
CA2470511C (en) 2001-12-21 2014-05-27 Novo Nordisk Health Care Ag Liquid composition of factor vii polypeptides
GB0202633D0 (en) * 2002-02-05 2002-03-20 Delta Biotechnology Ltd Stabilization of protein preparations
GB0207092D0 (en) * 2002-03-26 2002-05-08 Sod Conseils Rech Applic Stable pharmaceutical composition containing factor VIII
US20040009918A1 (en) * 2002-05-03 2004-01-15 Hanne Nedergaard Stabilised solid compositions of modified factor VII
WO2004000347A1 (en) 2002-06-21 2003-12-31 Novo Nordisk A/S Stabilised solid compositions of factor vii polypeptides
KR100714584B1 (ko) † 2002-12-27 2007-05-07 니혼긴센기카이가부시키가이샤 유가증권의 광학적 특징 검출용 광학센서장치
RU2005132164A (ru) * 2003-03-18 2006-06-10 Ново Нордиск Хелт Кэр Аг (Ch) Жидкие, водные фармацевтические композиции полипептидов фактора vii
US7897734B2 (en) * 2003-03-26 2011-03-01 Novo Nordisk Healthcare Ag Method for the production of proteins
WO2004103398A1 (en) * 2003-05-23 2004-12-02 Novo Nordisk Health Care Ag Protein stabilization in solution
CA2526120A1 (en) * 2003-06-03 2005-02-24 Cell Genesys, Inc. Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site
US7485291B2 (en) 2003-06-03 2009-02-03 Cell Genesys, Inc. Compositions and methods for generating multiple polypeptides from a single vector using a virus derived peptide cleavage site, and uses thereof
EP1641487B1 (de) 2003-06-25 2012-02-29 Novo Nordisk Health Care AG Flüssige zusammensetzungen von factor vii polypeptiden
DE602004023848D1 (de) * 2003-07-01 2009-12-10 Novo Nordisk Healthcare Ag Von factor vii polypeptiden
ES2574581T3 (es) 2003-08-14 2016-06-20 Novo Nordisk Health Care Ag Composición farmacéutica líquida acuosa de polipéptidos de tipo Factor VII
ES2229931B1 (es) * 2003-10-03 2006-01-16 Grifols, S.A. Composicion liquida bilogicamente estable de fviii, de fvw o del complejo fviii/fvw humanos.
US20050090551A1 (en) * 2003-10-27 2005-04-28 Board Of Trustees Of Southern Illinois University Therapeutic use of methionine for the treatment or prevention of mucositis
US7855274B2 (en) * 2003-12-03 2010-12-21 University Of Rochester Recombinant factor VIII having increased specific activity
AU2004298789A1 (en) * 2003-12-19 2005-06-30 Novo Nordisk Health Care Ag Stabilised compositions of factor VII polypeptides
US7422875B2 (en) 2004-07-20 2008-09-09 Board Of Regents Of The University Of Nebraska Compositions and methods for increasing protein production
WO2007022784A2 (en) * 2005-08-26 2007-03-01 Maxygen Holdings Ltd. Liquid factor vii composition
FR2908892B1 (fr) * 2006-11-21 2009-02-20 Hyphen Biomed Soc Par Actions Procede pour le dosage chromogenique de l'activite du facteur viii:c et necessaire de dosage chromogenique de l'activite du facteur viii:c,dans les plasmas ou les fractions therapeutiques
EP2711436A1 (de) 2007-11-01 2014-03-26 University Of Rochester Rekombinanter Faktor VIII mit erhöhter Stabilität
HUE036712T2 (hu) 2007-12-27 2018-07-30 Baxalta GmbH Sejttenyésztési eljárás
CA2742328C (en) 2008-11-07 2019-02-26 Baxter International Inc. Factor viii formulations
GB0915480D0 (en) 2009-09-04 2009-10-07 Arecor Ltd Stable formulation of factor viii
GB0915481D0 (en) 2009-09-04 2009-10-07 Arecor Ltd Stable manufacture of factor V111
JP5922141B2 (ja) 2010-11-05 2016-05-24 バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ 増加した比活性を有する抗血友病第ｖｉｉｉ因子の新規変異体
JP6178786B2 (ja) * 2011-05-13 2017-08-09 オクタファルマ・アーゲー 組換えｆｖｉｉｉの生産において真核細胞の生産性を向上させる方法
JP2014531910A (ja) 2011-10-18 2014-12-04 シーエスエル、リミテッド 再構成後の精製第ｖｉｉｉ因子の安定性を改善するための方法
CA2944349A1 (en) 2014-04-01 2015-10-08 Advantech Bioscience Farmaceutica Ltda. Stable factor viii formulations with low sugar-glycine
WO2015149144A2 (en) * 2014-04-01 2015-10-08 Advantech Bioscience Farmacêutica Ltda. Stabilization of factor viii without calcium as an excipient

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2593500B2 (ja) 1986-06-24 1997-03-26 ノルデイスク ゲントフテ エー／エス ▲ｖｉｉｉ▼因子フラグメントの凝固活性複合物の製造方法
SK282483B6 (sk) 1992-10-02 2002-02-05 Genetics Institute, Inc. Stabilná kompozícia koagulačného faktora VIII, spôsob jej prípravy a stabilizácie
SE9301581D0 (sv) * 1993-05-07 1993-05-07 Kabi Pharmacia Ab Protein formulation
AU7254894A (en) * 1993-07-23 1995-02-20 Baxter International Inc. Activated human factor viii and method of preparation
US5576291A (en) * 1993-09-13 1996-11-19 Baxter International Inc. Activated factor VIII as a therapeutic agent and method of treating factor VIII deficiency
EP0939797B1 (de) * 1996-10-11 2007-03-07 Invitrogen Corporation Definierte systeme zur kultivieurng epithelialer zellen und anwendung derselben
US5804420A (en) * 1997-04-18 1998-09-08 Bayer Corporation Preparation of recombinant Factor VIII in a protein free medium

Also Published As

Publication number Publication date
NO330048B1 (no) 2011-02-07
CA2378751C (en) 2012-11-06
NO20020120D0 (no) 2002-01-10
JP2003504345A (ja) 2003-02-04
ES2252028T3 (es) 2006-05-16
EP1194161B1 (de) 2005-11-23
EP1194161A1 (de) 2002-04-10
DE60024268T2 (de) 2006-08-03
WO2001003726A1 (en) 2001-01-18
NO20020120L (no) 2002-02-28
DE60024268D1 (de) 2005-12-29
AU6193300A (en) 2001-01-30
JP4674021B2 (ja) 2011-04-20
ATE310533T1 (de) 2005-12-15
CY1104986T1 (el) 2009-11-04
CA2378751A1 (en) 2001-01-18
NZ516400A (en) 2004-02-27
US6599724B1 (en) 2003-07-29
AU780415B2 (en) 2005-03-17
AR024735A1 (es) 2002-10-23

Similar Documents

Publication Publication Date Title
DK1194161T3 (da) Stabile faktor VIII-sammensatninger
DE60025198D1 (de) Stabile biozidale zusammensetzung
AR023440A1 (es) Composiciones antitranspirantes
DE60129705D1 (de) Monoalkylglycerinäther stabile zusammensetzungen
DE60014179D1 (de) Tintenzusammensetzungen
NO20014608L (no) Vekstfremmende sammensetninger
DE60020342D1 (de) Tiefeindringende antimikrobielle zusammensetzungen
IS6120A (is) Lyfjablanda
DE69921991D1 (de) Harzzusammensetzungen
ATE303787T1 (de) Schergelzusammensetzungen
DE60040350D1 (de) Weichspülerzusammensetzungen
ATE372372T1 (de) Zusammensetzungen enthaltend cyclodextrin
ITMI991754A0 (it) Composizioni cosmetiche
ID29785A (id) Komposisi-komposisi sampo
DE60021018D1 (de) Polymerzusammensetzungen
AR028197A1 (es) Composiciones antitranspirantes
NO20004497L (no) Modifisert faktor VIII
DE60007731D1 (de) Schweisshemmende zusammensetzungen
DE60036095D1 (de) Beschreibbare-abwaschbare tapete
ATE369830T1 (de) Schweisshemmende zusammensetzungen
ATE314049T1 (de) Schweisshemmende zusammensetzungen
NO20044305L (no) Stabile farmasoytiske blandinger inneholdende faktor VIII
DE60021259D1 (de) Reinigungsmittelzusammensetzungen
DE60007044D1 (de) Stabile biozide Zusammensetzungen
DE60035436D1 (de) Aerosolzusammensetzung